K Number
K171292
Device Name
A7 Anesthesia System
Date Cleared
2018-01-12

(255 days)

Regulation Number
868.5160
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The A7 Anesthesia System is a device used to administer to a patient, continuously or intermittently, a general inhalation anesthetic and to maintain a patient's ventilation. The A7 is intended for use by licensed clinicians, for patients requiring anesthesia within a health care facility, and can be used in adult and pediatric (including neonate, infant, child and adolescent) populations.
Device Description
The A7 Anesthesia System is a continuous flow inhalation gas anesthesia system that delivers anesthetic vapor and provides for automatic and manual modes of ventilation. The A7 incorporates 02, CO2, N2O and Agent concentration monitoring (Desflurane, Isoflurane, Enflurane, Sevoflurane and Halothane).
More Information

No
The summary does not mention AI, ML, or related terms, and the device description focuses on standard anesthesia system functionalities and monitoring.

Yes
The A7 Anesthesia System administers general inhalation anesthetic and maintains patient ventilation, both of which are therapeutic interventions.

No

The A7 Anesthesia System is described as a device used to administer anesthesia and maintain a patient's ventilation. While it incorporates monitoring of gas concentrations (O2, CO2, N2O, and various anesthetic agents), this monitoring is for the purpose of controlling the anesthetic delivery and ventilation, not for diagnosing a medical condition. Its primary function is therapeutic/supportive rather than diagnostic.

No

The device description clearly states it is a "continuous flow inhalation gas anesthesia system that delivers anesthetic vapor and provides for automatic and manual modes of ventilation," and mentions hardware components like "02, CO2, N2O and Agent concentration monitoring." The performance studies also include testing of various hardware modules (AG Module, Fresh Flow Optimizer, etc.) and compliance with hardware-related standards (AAMI / ANSI ES60601-1, IEC 60601-1-2, ISO 80601-2-13, etc.). This indicates it is a hardware device with integrated software, not a software-only medical device.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states the device is used to "administer to a patient... a general inhalation anesthetic and to maintain a patient's ventilation." This describes a device used on a patient for treatment and life support, not a device used to examine specimens from a patient to provide diagnostic information.
  • Device Description: The description focuses on the delivery of anesthetic gases, ventilation modes, and monitoring of gases within the system and patient's breathing circuit. It does not mention analyzing biological samples like blood, urine, or tissue.
  • Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
    • Analyzing biological specimens.
    • Providing diagnostic information about a patient's health status.
    • Using reagents or assays.
    • Measuring analytes in biological fluids.

The A7 Anesthesia System is a medical device used for anesthesia delivery and ventilation, which falls under a different regulatory category than In Vitro Diagnostics.

N/A

Intended Use / Indications for Use

The A7 Anesthesia System is a device used to administer to a patient, continuously or intermittently, a general inhalation anesthetic and to maintain a patient's ventilation.

The A7 is intended for use by licensed clinicians, for patients requiring anesthesia within a health care facility, and can be used in adult and pediatric (including neonate, infant, child and adolescent) populations.

Product codes

BSZ, CCK, NHO, CBS, CBQ, CBR, CCL, NHP, KDP

Device Description

The A7 Anesthesia System is a continuous flow inhalation gas anesthesia system that delivers anesthetic vapor and provides for automatic and manual modes of ventilation. The A7 incorporates O2, CO2, N2O and Agent concentration monitoring (Desflurane, Isoflurane, Enflurane, Sevoflurane and Halothane).

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

adult and pediatric (including neonate, infant, child and adolescent) populations.

Intended User / Care Setting

licensed clinicians, for patients requiring anesthesia within a health care facility

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Nonclinical testing and Performance:
The following areas have been tested:

  • Software
    • Unit testing
    • Integration testing
    • System testing
  • Performance
    • AG Module
    • Fresh Flow Optimizer
    • Sample Gas Return and CO2-absorbent
    • Suction
    • Heating Module
    • Power Supply
    • Thermal
    • Cleaning and Disinfection
    • Waveform Comparison
  • Biocompatibility
    • Volatile Organic Compounds
    • Particulate Testing
    • Cytotoxicity
    • Sensitization
    • Irritation / intracutaneous reactivity
    • Extractables and leachables (E&L) testing
    • Inorganic gases (O3, O2, CO2, NO2) testing
  • Human Factors Validation Testing
  • Testing as per consensus standards:
    • AAMI / ANSI ES60601-1:2005/(R)2012 and A1:2012, ,C1:2009/(R)2012 and A2:2010/(R)2012 Medical electrical equipment - Part 1: General Requirements for basic safety and essential performance
    • IEC 60601-1-2 Edition 3: 2007 Medical electrical equipment Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility - Requirements and tests
    • ISO 80601-2-13 First edition 2011-08-11 Medical electrical equipment Part 2-13: Particular requirements for basic safety and essential performance of an anesthetic workstation
    • ISO 80601-2-55 First edition 2011-12-15 Medical electrical equipment -Part 2-55: Particular requirements for the basic safety and essential performance of respiratory gas monitors
    • ASTM F1101-90 (Reapproved 2003) Standard Specification for Ventilators Intended for Use During Anesthesia
    • ISO 10079-3:2014 Medical suction equipment Part 3:Suction equipment powered from a vacuum or positive pressure gas source
    • AIM 7351731 medical electrical equipment and system electromagnetic immunity test for exposure to radio frequency identification readers - an aim standard. (General II (ES/EMC))

The functional and system level testing showed that the device continues to meet specifications and the performance of the device is equivalent to the predicate.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K151954

Reference Device(s)

K123211, K083050, K110213, K132530

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 868.5160 Gas machine for anesthesia or analgesia.

(a)
Gas machine for anesthesia —(1)Identification. A gas machine for anesthesia is a device used to administer to a patient, continuously or intermittently, a general inhalation anesthetic and to maintain a patient's ventilation. The device may include a gas flowmeter, vaporizer, ventilator, breathing circuit with bag, and emergency air supply.(2)
Classification. Class II (performance standards).(b)
Gas machine for analgesia —(1)Identification. A gas machine for analgesia is a device used to administer to a patient an analgesic agent, such as a nitrous oxide-oxygen mixture (maximum concentration of 70 percent nitrous oxide).(2)
Classification. Class II (performance standards).

0

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food & Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath in a smaller font.

January 12, 2018

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Yanhong Bai Manager Regulatory Affairs, Technical Regulation Department Mindray Building, Keji 12th Road South Hi-tech Industrial Park. Shenzhen, 518057 China

Re: K171292

Trade/Device Name: A7 Anesthesia System Regulation Number: 21 CFR 868.5160 Regulation Name: Gas Machine for Anesthesia or Analgesia Regulatory Class: Class II Product Code: BSZ, CCK, NHO, CBS, CBQ, CBR, CCL, NHQ, NHP, KDP Dated: December 8, 2017 Received: December 11, 2017

Dear Yanhong Bai:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

1

requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/SafetyReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Digitally signed by Tara A. Ryan -S
DN: c=US, o=U.S. Government, ou=HHS,
Tara A. Ryan -s ou=FDA, ou People, cn=Tara A. Ryan-5,
0.9.2342.19200300.100.1.1=1300030749
Date: 2018.01.12 11:26:05-05'00'

for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology. General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K171292

Device Name A7 Anesthesia System

Indications for Use (Describe)

The A7 Anesthesia System is a device used to administer to a patient, continuously or intermittently, a general inhalation anesthetic and to maintain a patient's ventilation.

The A7 is intended for use by licensed clinicians, for patients requiring anesthesia within a health care facility, and can be used in adult and pediatric (including neonate, infant, child and adolescent) populations.

Type of Use (Select one or both, as applicable)

☑ Prescription Use (Part 21 CFR 801 Subpart D)
☐ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

510(K) SUMMARY

In accordance with 21 CFR 807.87(h) and (21 CFR 807.92) the 510(k) Summary for the A7 Anesthesia System is provided below:

Device Common Name:Gas-Machine, Anesthesia
Device Proprietary Name:A7 Anesthesia System
Submitter:SHENZHEN MINDRAY BIO-MEDICAL
ELECTRONICS CO., LTD.
Mindray Building, Keji 12th Road South
High-tech Industrial Park, Nanshan
Shenzhen 518057, P.R. China
Tel: +86 755 81885635
Fax: +86 755 26582680
Contact:Yanhong Bai
Manager Regulatory Affairs
SHENZHEN MINDRAY BIO-MEDICAL
ELECTRONICS CO., LTD.
Mindray Building, Keji 12th Road South
High-tech Industrial Park, Nanshan
518057, P.R. China
Tel: +86 755 81885635
Fax: +86 755 26582680
E-mail: baiyanhong@mindray.com
Date Prepared:December 6th, 2017
Panel:Anesthesiology
Classification Regulation and Product Code:
Primary:
868.5160- BSZ Anesthesia Gas Machine Class II
Secondary:
868.1400 – CCK - Carbon Dioxide Gas Analyzer
868.1500 – NHO/CBQ/NHQ/NHP - Enflurane gas analyzer
868.1620 - CBS - Halothane Gas Analyzer
868.1700 – CBR - Nitrous Oxide Gas Analyzer
868.1720 – CCL- Oxygen Gas Analyzer
880.6740 – KDP- Vacuum Regulator

4

| 510(k) number | Trade or proprietor or model
name | Manufacturer |
|---------------|--------------------------------------|--------------------------------------------------------|
| K151954 | A7 Anesthesia System | Shenzhen Mindray Bio-
Medical Electronics Co., Ltd. |

Predicate Device:

Reference Devices:

| 510(k) number | Trade or proprietor or model
name | Manufacturer |
|---------------|--------------------------------------|--------------------------------------------------------|
| K123211 | A5 Anesthesia Delivery System | Shenzhen Mindray Bio-
Medical Electronics Co., Ltd. |
| K083050 | Evita XL Ventilator | Dräger Medical AG & Co. KG |
| K110213 | GE Datex-OhmedaAisys | Datex-Ohmeda Inc. |
| K132530 | GE Datex-OhmedaAisys CS2 | Datex-Ohmeda Inc. |

Indications for Use:

The A7 Anesthesia System is a device used to administer to a patient, continuously or intermittently, a general inhalation anesthetic and to maintain a patient's ventilation.

The A7 is intended for use by licensed clinicians, for patients requiring anesthesia within a health care facility, and can be used in adult and pediatric (including neonate, infant, child and adolescent) populations.

Device Description:

The A7 Anesthesia System is a continuous flow inhalation gas anesthesia system that delivers anesthetic vapor and provides for automatic and manual modes of ventilation. The A7 incorporates 02, CO2, N2O and Agent concentration monitoring (Desflurane, Isoflurane, Enflurane, Sevoflurane and Halothane).

Nonclinical testing and Performance:

The following areas have been tested:

  • . Software
    • o Unit testing
    • Integration testing o
    • o System testing
  • Performance ●
    • o AG Module
    • Fresh Flow Optimizer O
    • Sample Gas Return and CO2-absorbent O

5

  • Suction o
  • Heating Module O
  • Power Supply O
  • Thermal O
  • Cleaning and Disinfection o
  • Waveform Comparison o
  • Biocompatibility ●
    • Volatile Organic Compounds o
    • Particulate Testing O
    • Cytotoxicity O
    • Sensitization O
    • Irritation / intracutaneous reactivity O
    • Extractables and leachables (E&L) testing O
    • Inorganic gases (03, 02, CO2, NO2) testing O
  • Human Factors Validation Testing ●
  • . Testing as per consensus standards:
    • o AAMI / ANSI ES60601-1:2005/(R)2012 and A1:2012, ,C1:2009/(R)2012 and A2:2010/(R)2012 Medical electrical equipment - Part 1: General Requirements for basic safety and essential performance
    • IEC 60601-1-2 Edition 3: 2007 Medical electrical equipment Part 1-2: General o requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility - Requirements and tests
    • ISO 80601-2-13 First edition 2011-08-11 Medical electrical equipment Part 2- O 13: Particular requirements for basic safety and essential performance of an anesthetic workstation
    • ISO 80601-2-55 First edition 2011-12-15 Medical electrical equipment -Part 2-55: o Particular requirements for the basic safety and essential performance of respiratory gas monitors
    • ASTM F1101-90 (Reapproved 2003) Standard Specification for Ventilators O Intended for Use During Anesthesia
    • ISO 10079-3:2014 Medical suction equipment Part 3:Suction equipment o powered from a vacuum or positive pressure gas source
    • AIM 7351731 medical electrical equipment and system electromagnetic O immunity test for exposure to radio frequency identification readers - an aim standard. (General II (ES/EMC))

6

The functional and system level testing showed that the device continues to meet specifications and the performance of the device is equivalent to the predicate.

Substantial Equivalence:

Comparison of Indications:

Both the predicate device and the subject A7 Anesthesia System are gas anesthesia machine used to administer to a patient, continuously or intermittently, a general inhalation anesthetic and to maintain a patient's ventilation. The indications for use of the subject device (A7 Anesthesia System) have been modified to add the definition of the pediatric population subgroup. All of the pediatric population subgroup was cleared in the predicate device A7 Anesthesia System (K151954). In conclusion, the minor changes to the indications for use do not change the intended use of the A7 Anesthesia System.

7

Comparison of Technological Characteristics:

The table below compares the key technological feature of the subject device to the predicate device (A7 Anesthesia System (K151954)).

Device Comparison Table

| | Technical
Characteristics | Subject Device
A7 Anesthesia System
(subject device) | Predicate Device
A7 Anesthesia System
(K151954) |
|-------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------|
| | Vaporizers | Two or Three, variable bypass | Two or three, variable bypass |
| | Agent - Sevoflurane | Yes | Yes |
| | Agent - Isoflurane | Yes | Yes |
| | Agent - Desflurane | Yes | Yes |
| | Agent - Halothane | Yes | Yes |
| | Agent - Enflurane | Yes | Yes |
| | Automatic Ventilator | Yes | Yes |
| | Bellows | Yes | Yes |
| | Bellows Volume | 1500mL | 1500mL |
| Ventilation Modes | | | |
| | VCV | Yes | Yes |
| | PCV | Yes | Yes |
| | PCV – VG | Yes | Yes |
| | SIMV - VC | Yes | Yes |
| | SIMV - PC | Yes | Yes |
| | PS | Yes | Yes |
| Specifications | | | |
| | Tidal Volume | Yes | Yes |
| | Range, ml | 20 to 1500 | 20 to 1500 |
| | Minute Volume | Yes | Yes |
| | Rate, bpm | 4 to 100 bpm | 4 to 100 bpm |
| | I:E Ratio | 4:1 to 1:8 with 0.5 increment | 4:1 to 1:8 with 0.5 increment |
| | Inspiratory Pause | Off, 5 to 60% of insp. Period | Off, 5 to 60% of insp. Period |
| | Air Flow Range | 0 to 15 L/min | 0 to 15 L/min |
| Fresh Gas | N2O Flow Range | 0 to 12 L/min | 0 to 12 L/min |
| | O2 Flow Range | 0 to 15 L/min | 0 to 15 L/min |
| Technical
Characteristics | Subject Device
A7 Anesthesia System
(subject device) | Predicate Device
A7 Anesthesia System
(K151954) | |
| Individual Gas Flow
Accuracy | ±50 ml/min or ±5% of setting
value, whichever is greater | ±50 ml/min or ±5% of setting
value, whichever is greater | |
| Pressure Limit, cm H₂O | 0 to 100cm H₂O | 0 to 100cm H₂O | |
| PEEP, cm H₂O | Off, 3 to 30, 1 cm H₂O increment | Off, 3 to 30, 1 cm H₂O increment | |
| System Checks | Auto at start | Auto at start | |
| Airway Pressure Measured at | Inspiratory | Inspiratory | |
| High/Low Airway Pressure Alarm | Yes | Yes | |
| Pressure Limiting Alarm | Yes | Yes | |
| Sub Atmospheric Pressure Alarm | Yes | Yes | |
| Continuous Press Alarm | Yes | Yes | |
| Apnea >2 Minute Alarm | Yes | Yes | |
| Apnea Alarm | Yes | Yes | |
| High/Low Minute Volume Alarm | Yes | Yes | |
| High/Low O₂ Concentration Alarm | Yes | Yes | |
| Heated Breathing Circuit | Yes | Yes | |
| Spirometry: Pressure-Volume and
Flow-Volume loops | Yes | Yes | |
| Anesthetic Gas Module Sampling Rate | Adult/pediatric: 120, 150,
200mL/min
Neonate: 70, 90, 120mL/min | High volume: 120, 150,
200mL/min
Low volume: 70, 90, 120mL/min | |
| Anesthetic Gas Module Sampling
Delay Time: | 10%: unspecified | 0 to 1%: +/-.1%
1 to 5%: +/-.2%
5 to 7%: +/-.3%
7 to10%: +/-.5%

10%: unspecified | |
| Anesthetic Gas Module Accuracy
N₂O: | 0 to 20%: +/-2%
20 to 100%: +/-3% | 0 to 20%: +/-2%
20 to 100%: +/-3% | |
| Technical
Characteristics | Subject Device
A7 Anesthesia System
(subject device) | Predicate Device
A7 Anesthesia System
(K151954) | |
| Anesthetic Gas Module Accuracy
Desflurane: | 0 to 1%: +/-.15%
1 to 5%: +/-.2%
5 to 10%: +/-.4%
10 to 15%: +/-.6%
15 to 18%: +/-1%
18%: unspecified | 0 to 1%: +/-.15%
1 to 5%: +/-.2%
5 to 10%: +/-.4%
10 to 15%: +/-.6%
15 to 18%: +/-1%
18%: unspecified | |
| Anesthetic Gas Module Accuracy
Sevoflurane: | 0 to 1%: +/-.15%
1 to 5%: +/-.2%
5 to 8%: +/-.4%
8%: unspecified | 0 to 1%: +/-.15%
1 to 5%: +/-.2%
5 to 8%: +/-.4%
8%: unspecified | |
| Anesthetic Gas Module Accuracy
Enflurane/Isoflurane/
Halothane: | 0 to 1%: +/-.15%
1 to 5%: +/-.2%
5%: unspecified | 0 to 1%: +/-.15%
1 to 5%: +/-.2%
5%: unspecified | |
| Anesthetic Gas Module Accuracy O2: | 0 to 25%: +/-1%
25 to 80%: +/-2%
80 to 100%: +/-3% | 0 to 25%: +/-1%
25 to 80%: +/-2%
80 to 100%: +/-3% | |
| Anesthetic Gas Module Accuracy
awRR: | 2 to 60rpm: +/-1rpm
60rpm: unspecified | 2 to 60rpm: +/-1rpm
60rpm: unspecified | |
| Anesthetic Gas Module
Measurement
Rise Time: | CO2: